Biocon releases new drug for treatment of cancer affecting the lung, kidney, cervical, ovaries and brain
The drug is given with chemotherapy to patients suffering from lung cancer, metastatic renal cell carcinoma and recurrent ovarian cancer.
The drug is given with chemotherapy to patients suffering from lung cancer, metastatic renal cell carcinoma and recurrent ovarian cancer.
Should the government ease norms for clinical trials?
Kiran Mazumdar Shaw wins 2014 Othmer Gold Medal
Regulatory nod for Biocon to market cancer drug
Can Biocon's Alzumab prove to be the breakthrough cure for psoriasis?
Biocon receives marketing approval for its Psoriasis drug in India
GE to invest in Indian research firm Biocon
Abott and Syngene inaugurate its first nutrition research and development centre in Bengaluru
The drug is given with chemotherapy to patients suffering from lung cancer, metastatic renal cell carcinoma and recurrent ovarian cancer.
Should the government ease norms for clinical trials?
Kiran Mazumdar Shaw wins 2014 Othmer Gold Medal
Regulatory nod for Biocon to market cancer drug
Can Biocon's Alzumab prove to be the breakthrough cure for psoriasis?
Biocon receives marketing approval for its Psoriasis drug in India
GE to invest in Indian research firm Biocon
Abott and Syngene inaugurate its first nutrition research and development centre in Bengaluru